1 / 14
文档名称:

重症感染指导.doc

格式:doc   大小:140KB   页数:14页
下载后只包含 1 个 DOC 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

重症感染指导.doc

上传人:s1188831 2022/6/22 文件大小:140 KB

下载得到文件列表

重症感染指导.doc

文档介绍

文档介绍:Definitions
MDR A. baumannii was defined as resistance to at least two b-lactam antimicrobials (including ceftazidime, factors; the results being presented as an odds ratio (OR with a 95% confidence inter-val (95% logistic regression analysis, using the backward likelihood ratio selection method, was used to assess independent factors related to contracting MDR A. baumannii bacteremia and those related to p-value ≤ was considered statistically significant.
RESULTS
During the 3-year period of the study, there were 84 episodes in 79 patients with positive blood cultures for A. baumannii, indicating an incidence of cases per 10,000 hospital these, the incidences of MDR- and PDR- A. bau-mannii bacteremia were and cases per 10,000 hospital admissions, respec- was an increasing trend in antimicrobial resistance to several drugs during the 3-year study (Fig 1.
Medical records were available for 65 cases (%.Of these, 16 cases were excluded from the study due to contami-nation (6 cases, mixed infection (9 cases and transfer to another hospital (1 case. Among the remaining 49 cases, 25 (51% and 24 cases (49%, respectively, had non-MDR and MDR A. baumannii bacteremia and 15 of the 24 MDR A. baumannii cases (% had PDR A. baumannii infection.
The demographic data are presented in Table 1. The mean age of the two patient groups (ie, non-MDR and MDR
% Resistance % Resistance 1009080706050403020100
1009080706050403020100
CPO
CAZ
CTX
SAM
SCFP
TZP
IPM
MEM
OFX SXT
200520062007
20052006

2007
AK NET CFX A. baumannii bacteremia were compa-rable [ (SD, vs (SD, years]. There were no differences in sex distribution or admission wards. All pa-tients with MDR A. baumannii bacteremia, compared to two-thirds of those with non-MDR A. baumannii infection, had hospital-acquired infections (p =. The majority of patients in the two groups had similar underlying diseases except fo